Additionally, KIF2C affected the stemness of HCC cells by interfering with several key pathways including mTORC1 (mammalian target of rapamycin complex 1) [144], Ras/MAPK (rat sarcoma/mitogen-activated protein kinase) [98], Wnt/β-catenin (wingless/beta-catenin) [144] and MEK/ERK (mitogen-activated protein kinase kinase/extracellular signal-regulated kinases) [145]. Here, KIF2C is linked to hepatocellular carcinoma.